Organic solvents are integral to the way we do chemistry today, but they are also hazardous, and many are derived from non-renewable petroleum. Adapting reactions, workups, and isolations to aqueous ...
Tegaserod is a novel selective serotonin receptor type-4 (5-HT4) partial agonist with structural similarity to 5-HT Tegaserod stimulates small bowel and colonic motility and helps to normalise GI ...
Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders
SPC-15 is a novel serotonin 4 (5-HT4) receptor agonist that utilizes biomarkers for the treatment of PTSD, anxiety, and other stress-induced affective disorders. SPC-15 is being developed as an ...
“Securing this patent strengthens our intellectual property portfolio, continuing progress on naronapride’s global clinical development,” said Dr. Peter Milner, M.D., FACC, Chairman and CEO of ...
A study published in Biological Psychiatry investigated the role of the 5-HT4 receptor (5-HT4R ... The findings open up the possibility of using 5-HT4R agonists as an augmentation strategy to ...
Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders
About SPC-15 SPC-15 is a novel serotonin 4 (5-HT4) receptor agonist that utilizes biomarkers for the treatment of PTSD, anxiety, and other stress-induced affective disorders. SPC-15 is being developed ...
Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders
This new formulation, which targets both the serotonin 5-HT4 receptor (5-HT4R ... The study highlights the proposed efficacy of combining SPC-15, a 5-HT4R agonist, with an NMDAR antagonist to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback